206 related articles for article (PubMed ID: 32967901)
1. Comparison of Agar Dilution to Broth Microdilution for Testing
Albano M; Karau MJ; Schuetz AN; Patel R
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 32967901
[TBL] [Abstract][Full Text] [Related]
2. Cefiderocol Antimicrobial Susceptibility Testing Considerations: the Achilles' Heel of the Trojan Horse?
Simner PJ; Patel R
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 32727829
[TBL] [Abstract][Full Text] [Related]
3.
Hackel MA; Tsuji M; Yamano Y; Echols R; Karlowsky JA; Sahm DF
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158270
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol, determined using iron-depleted cation-adjusted Mueller-Hinton broth.
Hackel MA; Tsuji M; Yamano Y; Echols R; Karlowsky JA; Sahm DF
Diagn Microbiol Infect Dis; 2019 Aug; 94(4):321-325. PubMed ID: 31029489
[TBL] [Abstract][Full Text] [Related]
5. Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-Negative Bacilli: a Comparison of Disk Diffusion to Broth Microdilution.
Morris CP; Bergman Y; Tekle T; Fissel JA; Tamma PD; Simner PJ
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 32938734
[TBL] [Abstract][Full Text] [Related]
6. Analysis of In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Gram-Negative Bacilli by Broth Microdilution and Disk Diffusion Method: A Single-Center Study in Odisha, India.
Nayak G; Behera B; Mohanty S; Kar P; Jena J
Infect Drug Resist; 2022; 15():5887-5897. PubMed ID: 36237292
[TBL] [Abstract][Full Text] [Related]
7.
Hackel MA; Tsuji M; Yamano Y; Echols R; Karlowsky JA; Sahm DF
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630181
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activities of cefiderocol against Gram-negative clinical strains isolated from China in 2020.
Kohira N; Hackel MA; Oota M; Takemura M; Hu F; Mizuno H; Sahm DF; Yamano Y
J Glob Antimicrob Resist; 2023 Mar; 32():181-186. PubMed ID: 36513320
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015.
Karlowsky JA; Hackel MA; Tsuji M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Apr; 53(4):456-466. PubMed ID: 30471402
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline.
Babaei S; Haeili M
BMC Infect Dis; 2021 Jul; 21(1):709. PubMed ID: 34315422
[TBL] [Abstract][Full Text] [Related]
11. In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium.
Oueslati S; Bogaerts P; Dortet L; Bernabeu S; Ben Lakhal H; Longshaw C; Glupczynski Y; Naas T
Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290010
[TBL] [Abstract][Full Text] [Related]
12. Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing.
Matuschek E; Longshaw C; Takemura M; Yamano Y; Kahlmeter G
J Antimicrob Chemother; 2022 May; 77(6):1662-1669. PubMed ID: 35289853
[TBL] [Abstract][Full Text] [Related]
13. Two-Site Evaluation of the Colistin Broth Disk Elution Test To Determine Colistin
Simner PJ; Bergman Y; Trejo M; Roberts AA; Marayan R; Tekle T; Campeau S; Kazmi AQ; Bell DT; Lewis S; Tamma PD; Humphries R; Hindler JA
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30282791
[TBL] [Abstract][Full Text] [Related]
14. Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis.
Karakonstantis S; Rousaki M; Vassilopoulou L; Kritsotakis EI
Clin Microbiol Infect; 2024 Feb; 30(2):178-188. PubMed ID: 37666449
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014-2018 studies in Spain.
Cercenado E; Cardenoso L; Penin R; Longshaw C; Henriksen AS; Pascual A
J Glob Antimicrob Resist; 2021 Sep; 26():292-300. PubMed ID: 34274538
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of cefiderocol against clinically important carbapenem non-susceptible Gram-negative bacteria from Saudi Arabia.
Alzayer M; Alghoribi MF; Alalwan B; Alreheli A; Aljohani S; Bosaeed M; Doumith M
J Glob Antimicrob Resist; 2023 Mar; 32():176-180. PubMed ID: 36481491
[TBL] [Abstract][Full Text] [Related]
17. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales.
Bonnin RA; Emeraud C; Jousset AB; Naas T; Dortet L
Clin Microbiol Infect; 2022 Aug; 28(8):1156.e1-1156.e5. PubMed ID: 35533970
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014-2018.
Gant V; Hussain A; Bain M; Longshaw C; Henriksen AS
J Glob Antimicrob Resist; 2021 Dec; 27():1-11. PubMed ID: 34329792
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Variability in Interpretation of Disk Diffusion Testing for Cefiderocol Using Different Brands of Mueller-Hinton Agar.
Potter RF; Wallace MA; Muenks CE; Alvarado K; Yarbrough ML; Burnham CD
J Appl Lab Med; 2023 May; 8(3):523-534. PubMed ID: 36738243
[TBL] [Abstract][Full Text] [Related]
20. Simple Phenotypic Tests To Improve Accuracy in Screening Chromosomal and Plasmid-Mediated Colistin Resistance in Gram-Negative Bacilli.
Pasteran F; Danze D; Menocal A; Cabrera C; Castillo I; Albornoz E; Lucero C; Rapoport M; Ceriana P; Corso A
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33115847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
